US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 12.570
  • +0.090+0.72%
Trading Oct 2 11:16 ET
529.37MMarket Cap-4067P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
409.67%241.08M
152.17%164.05M
37.02%136.97M
37.02%136.97M
53.70%147.42M
-57.67%47.3M
-52.32%65.05M
12.14%99.96M
12.14%99.96M
-9.70%95.91M
-Cash and cash equivalents
992.92%219.97M
259.71%131.44M
71.46%95M
71.46%95M
315.90%119.31M
-75.06%20.13M
-65.33%36.54M
24.91%55.41M
24.91%55.41M
-48.16%28.69M
-Short-term investments
-22.33%21.11M
14.35%32.61M
-5.81%41.97M
-5.81%41.97M
-58.18%28.11M
-12.48%27.17M
-8.21%28.51M
-0.50%44.56M
-0.50%44.56M
32.15%67.23M
Receivables
12.32%17.42M
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
8.42%12.7M
8.42%12.7M
21.13%9.43M
-Accounts receivable
12.32%17.42M
13.33%14.16M
21.56%15.44M
21.56%15.44M
36.25%12.85M
33.72%15.51M
31.52%12.49M
8.42%12.7M
8.42%12.7M
21.13%9.43M
Inventory
49.20%7.44M
32.51%7.24M
31.17%5.67M
31.17%5.67M
2.88%5M
-1.17%4.99M
14.93%5.47M
-10.49%4.33M
-10.49%4.33M
27.68%4.86M
Restricted cash
1.10%825K
1.11%823K
0.98%821K
0.98%821K
0.62%817K
0.62%816K
48.00%814K
-33.69%813K
-33.69%813K
-33.77%812K
Other current assets
-4.05%12.21M
-13.63%10.49M
-7.39%10.28M
-7.39%10.28M
51.59%16.04M
21.95%12.72M
30.95%12.15M
48.49%11.1M
48.49%11.1M
73.07%10.58M
Total current assets
242.99%278.97M
105.02%196.76M
31.25%169.19M
31.25%169.19M
49.78%182.12M
-41.75%81.33M
-40.21%95.97M
12.69%128.91M
12.69%128.91M
-2.83%121.59M
Non current assets
Net PPE
-39.34%1.83M
-41.46%2.01M
-37.05%2.36M
-37.05%2.36M
-34.81%2.73M
-18.92%3.02M
26.08%3.43M
19.13%3.75M
19.13%3.75M
23.23%4.19M
-Gross PPE
-9.36%5.98M
-10.52%6.08M
-8.51%6.31M
-8.51%6.31M
-8.58%6.49M
3.06%6.59M
31.69%6.8M
28.40%6.9M
28.40%6.9M
31.24%7.1M
-Accumulated depreciation
-15.94%-4.15M
-21.03%-4.08M
-25.46%-3.95M
-25.46%-3.95M
-29.10%-3.76M
-33.64%-3.58M
-37.94%-3.37M
-41.51%-3.15M
-41.51%-3.15M
-44.76%-2.91M
Investments and advances
-97.45%203K
-95.27%481K
--4.5M
--4.5M
--6.51M
1,084.25%7.97M
1,408.16%10.17M
--0
--0
--0
Other non current assets
-72.11%848K
-60.87%1.32M
-23.62%2.26M
-23.62%2.26M
-15.55%2.28M
43.24%3.04M
88.52%3.38M
93.16%2.96M
93.16%2.96M
34.97%2.69M
Total non current assets
-79.46%2.88M
-77.54%3.81M
35.95%9.13M
35.95%9.13M
67.32%11.51M
115.25%14.03M
227.12%16.98M
25.32%6.71M
25.32%6.71M
-27.31%6.88M
Total assets
195.56%281.85M
77.57%200.57M
31.48%178.31M
31.48%178.31M
50.72%193.63M
-34.75%95.36M
-31.84%112.95M
13.26%135.62M
13.26%135.62M
-4.55%128.47M
Liabilities
Current liabilities
Payables
78.51%8.32M
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-4.48%5.53M
-4.48%5.53M
-37.32%2.55M
-accounts payable
78.51%8.32M
-10.18%6.26M
17.86%6.51M
17.86%6.51M
58.78%4.04M
89.62%4.66M
64.57%6.97M
-4.48%5.53M
-4.48%5.53M
-37.32%2.55M
Current accrued expenses
31.45%15.44M
17.09%11.9M
46.21%10.02M
46.21%10.02M
47.44%10.04M
89.73%11.74M
78.22%10.16M
8.55%6.86M
8.55%6.86M
-2.73%6.81M
Other current liabilities
-0.58%3.62M
0.38%3.2M
17.83%3.86M
17.83%3.86M
17.73%3.55M
22.80%3.64M
-20.55%3.19M
-1.62%3.28M
-1.62%3.28M
33.07%3.02M
Current liabilities
27.86%34.22M
4.38%26.34M
30.51%31.21M
30.51%31.21M
35.73%25.79M
48.36%26.77M
32.18%25.23M
6.86%23.92M
6.86%23.92M
-4.07%19M
Non current liabilities
Long term debt and capital lease obligation
-1.27%98.24M
-1.12%98.23M
0.27%99.4M
0.27%99.4M
35.02%99.54M
36.85%99.51M
39.78%99.34M
24,805.28%99.12M
24,805.28%99.12M
11,868.51%73.73M
-Long term debt
-0.49%97.81M
-0.36%97.59M
1.04%98.55M
1.04%98.55M
37.08%98.52M
38.06%98.3M
38.34%97.94M
--97.54M
--97.54M
--71.87M
-Long term capital lease obligation
-64.85%425K
-54.60%637K
-46.78%844K
-46.78%844K
-44.72%1.03M
-20.20%1.21M
406.50%1.4M
298.49%1.59M
298.49%1.59M
201.30%1.86M
Derivative product liabilities
10.88%115.88M
10.83%112.95M
10.92%109.72M
10.92%109.72M
11.52%107.28M
11.82%104.51M
13.51%101.91M
15.41%98.92M
15.41%98.92M
20.35%96.19M
Total non current liabilities
4.97%217.31M
4.94%214.37M
5.59%212.31M
5.59%212.31M
21.46%209.84M
22.49%207.03M
24.79%204.27M
126.03%201.06M
126.03%201.06M
107.49%172.76M
Total liabilities
7.59%251.54M
4.88%240.71M
8.24%243.52M
8.24%243.52M
22.88%235.63M
24.99%233.8M
25.56%229.51M
102.08%224.98M
102.08%224.98M
86.05%191.76M
Shareholders'equity
Share capital
75.00%112K
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
3.28%63K
3.28%63K
3.28%63K
-common stock
75.00%112K
54.69%99K
41.27%89K
41.27%89K
33.33%84K
3.23%64K
3.23%64K
3.28%63K
3.28%63K
3.28%63K
Retained earnings
-17.99%-745.04M
-17.18%-711.63M
-17.72%-679.35M
-17.72%-679.35M
-19.17%-653.33M
-20.87%-631.45M
-22.51%-607.32M
-23.49%-577.1M
-23.49%-577.1M
-24.92%-548.24M
Paid-in capital
57.22%775.27M
36.82%671.44M
25.88%614.04M
25.88%614.04M
26.05%611.39M
2.41%493.11M
2.53%490.74M
2.54%487.79M
2.54%487.79M
3.13%485.04M
Gains losses not affecting retained earnings
79.87%-31K
17.78%-37K
111.21%12K
111.21%12K
13.55%-134K
-175.00%-154K
34.78%-45K
-328.00%-107K
-328.00%-107K
-3,975.00%-155K
Total stockholders'equity
121.90%30.31M
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
-1,162.18%-89.36M
-1,162.18%-89.36M
-300.67%-63.29M
Total equity
121.90%30.31M
65.57%-40.13M
27.02%-65.21M
27.02%-65.21M
33.65%-41.99M
-238.36%-138.43M
-582.64%-116.55M
-1,162.18%-89.36M
-1,162.18%-89.36M
-300.67%-63.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 409.67%241.08M152.17%164.05M37.02%136.97M37.02%136.97M53.70%147.42M-57.67%47.3M-52.32%65.05M12.14%99.96M12.14%99.96M-9.70%95.91M
-Cash and cash equivalents 992.92%219.97M259.71%131.44M71.46%95M71.46%95M315.90%119.31M-75.06%20.13M-65.33%36.54M24.91%55.41M24.91%55.41M-48.16%28.69M
-Short-term investments -22.33%21.11M14.35%32.61M-5.81%41.97M-5.81%41.97M-58.18%28.11M-12.48%27.17M-8.21%28.51M-0.50%44.56M-0.50%44.56M32.15%67.23M
Receivables 12.32%17.42M13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M8.42%12.7M8.42%12.7M21.13%9.43M
-Accounts receivable 12.32%17.42M13.33%14.16M21.56%15.44M21.56%15.44M36.25%12.85M33.72%15.51M31.52%12.49M8.42%12.7M8.42%12.7M21.13%9.43M
Inventory 49.20%7.44M32.51%7.24M31.17%5.67M31.17%5.67M2.88%5M-1.17%4.99M14.93%5.47M-10.49%4.33M-10.49%4.33M27.68%4.86M
Restricted cash 1.10%825K1.11%823K0.98%821K0.98%821K0.62%817K0.62%816K48.00%814K-33.69%813K-33.69%813K-33.77%812K
Other current assets -4.05%12.21M-13.63%10.49M-7.39%10.28M-7.39%10.28M51.59%16.04M21.95%12.72M30.95%12.15M48.49%11.1M48.49%11.1M73.07%10.58M
Total current assets 242.99%278.97M105.02%196.76M31.25%169.19M31.25%169.19M49.78%182.12M-41.75%81.33M-40.21%95.97M12.69%128.91M12.69%128.91M-2.83%121.59M
Non current assets
Net PPE -39.34%1.83M-41.46%2.01M-37.05%2.36M-37.05%2.36M-34.81%2.73M-18.92%3.02M26.08%3.43M19.13%3.75M19.13%3.75M23.23%4.19M
-Gross PPE -9.36%5.98M-10.52%6.08M-8.51%6.31M-8.51%6.31M-8.58%6.49M3.06%6.59M31.69%6.8M28.40%6.9M28.40%6.9M31.24%7.1M
-Accumulated depreciation -15.94%-4.15M-21.03%-4.08M-25.46%-3.95M-25.46%-3.95M-29.10%-3.76M-33.64%-3.58M-37.94%-3.37M-41.51%-3.15M-41.51%-3.15M-44.76%-2.91M
Investments and advances -97.45%203K-95.27%481K--4.5M--4.5M--6.51M1,084.25%7.97M1,408.16%10.17M--0--0--0
Other non current assets -72.11%848K-60.87%1.32M-23.62%2.26M-23.62%2.26M-15.55%2.28M43.24%3.04M88.52%3.38M93.16%2.96M93.16%2.96M34.97%2.69M
Total non current assets -79.46%2.88M-77.54%3.81M35.95%9.13M35.95%9.13M67.32%11.51M115.25%14.03M227.12%16.98M25.32%6.71M25.32%6.71M-27.31%6.88M
Total assets 195.56%281.85M77.57%200.57M31.48%178.31M31.48%178.31M50.72%193.63M-34.75%95.36M-31.84%112.95M13.26%135.62M13.26%135.62M-4.55%128.47M
Liabilities
Current liabilities
Payables 78.51%8.32M-10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M-4.48%5.53M-4.48%5.53M-37.32%2.55M
-accounts payable 78.51%8.32M-10.18%6.26M17.86%6.51M17.86%6.51M58.78%4.04M89.62%4.66M64.57%6.97M-4.48%5.53M-4.48%5.53M-37.32%2.55M
Current accrued expenses 31.45%15.44M17.09%11.9M46.21%10.02M46.21%10.02M47.44%10.04M89.73%11.74M78.22%10.16M8.55%6.86M8.55%6.86M-2.73%6.81M
Other current liabilities -0.58%3.62M0.38%3.2M17.83%3.86M17.83%3.86M17.73%3.55M22.80%3.64M-20.55%3.19M-1.62%3.28M-1.62%3.28M33.07%3.02M
Current liabilities 27.86%34.22M4.38%26.34M30.51%31.21M30.51%31.21M35.73%25.79M48.36%26.77M32.18%25.23M6.86%23.92M6.86%23.92M-4.07%19M
Non current liabilities
Long term debt and capital lease obligation -1.27%98.24M-1.12%98.23M0.27%99.4M0.27%99.4M35.02%99.54M36.85%99.51M39.78%99.34M24,805.28%99.12M24,805.28%99.12M11,868.51%73.73M
-Long term debt -0.49%97.81M-0.36%97.59M1.04%98.55M1.04%98.55M37.08%98.52M38.06%98.3M38.34%97.94M--97.54M--97.54M--71.87M
-Long term capital lease obligation -64.85%425K-54.60%637K-46.78%844K-46.78%844K-44.72%1.03M-20.20%1.21M406.50%1.4M298.49%1.59M298.49%1.59M201.30%1.86M
Derivative product liabilities 10.88%115.88M10.83%112.95M10.92%109.72M10.92%109.72M11.52%107.28M11.82%104.51M13.51%101.91M15.41%98.92M15.41%98.92M20.35%96.19M
Total non current liabilities 4.97%217.31M4.94%214.37M5.59%212.31M5.59%212.31M21.46%209.84M22.49%207.03M24.79%204.27M126.03%201.06M126.03%201.06M107.49%172.76M
Total liabilities 7.59%251.54M4.88%240.71M8.24%243.52M8.24%243.52M22.88%235.63M24.99%233.8M25.56%229.51M102.08%224.98M102.08%224.98M86.05%191.76M
Shareholders'equity
Share capital 75.00%112K54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K3.28%63K3.28%63K3.28%63K
-common stock 75.00%112K54.69%99K41.27%89K41.27%89K33.33%84K3.23%64K3.23%64K3.28%63K3.28%63K3.28%63K
Retained earnings -17.99%-745.04M-17.18%-711.63M-17.72%-679.35M-17.72%-679.35M-19.17%-653.33M-20.87%-631.45M-22.51%-607.32M-23.49%-577.1M-23.49%-577.1M-24.92%-548.24M
Paid-in capital 57.22%775.27M36.82%671.44M25.88%614.04M25.88%614.04M26.05%611.39M2.41%493.11M2.53%490.74M2.54%487.79M2.54%487.79M3.13%485.04M
Gains losses not affecting retained earnings 79.87%-31K17.78%-37K111.21%12K111.21%12K13.55%-134K-175.00%-154K34.78%-45K-328.00%-107K-328.00%-107K-3,975.00%-155K
Total stockholders'equity 121.90%30.31M65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M-1,162.18%-89.36M-1,162.18%-89.36M-300.67%-63.29M
Total equity 121.90%30.31M65.57%-40.13M27.02%-65.21M27.02%-65.21M33.65%-41.99M-238.36%-138.43M-582.64%-116.55M-1,162.18%-89.36M-1,162.18%-89.36M-300.67%-63.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data